Showing 1,801 - 1,820 results of 18,058 for search 'significant ((((((gap decrease) OR (step decrease))) OR (we decrease))) OR (a decrease))', query time: 0.60s Refine Results
  1. 1801

    ANOM analysis of evaluated criteria K1–K5. by Roman Vavrek (13200141)

    Published 2024
    “…Based on the performed analyses, we can see that significant differences result from their reduction. …”
  2. 1802

    Resistant Starch Nanoparticles Induce Colitis through Lysosomal Exocytosis in Mice by Chenglu Peng (19935965)

    Published 2024
    “…This, in turn, triggered the TFEB signaling pathway and thus upregulated the lysosomal exocytosis level, leading to lysosomal enzymes to be released to the intestinal lumen. As a result, a decreased number of intestinal goblet cells, diminished tight junction protein expression, and imbalanced intestinal flora in mice were observed. …”
  3. 1803

    Exclusion and enrollment summary from NHANES. by Lu Han (151620)

    Published 2025
    “…Individuals under 30 showed no significant differences. A unit increase below 9.30 in Log2-PMR reduced HCV risk by 0.60-fold. …”
  4. 1804
  5. 1805
  6. 1806
  7. 1807
  8. 1808
  9. 1809

    Reagent list. by Adrienne J. Bradley (20861948)

    Published 2025
    “…We found a significant increase of Iba-1, indicative of microglia activation, although the overall levels of IL-1β, IL-6, TNFα, IL-4, IL-10, and TGFβ mRNA transcripts were not different between the treatment groups. …”
  10. 1810

    Data for figures. by Adrienne J. Bradley (20861948)

    Published 2025
    “…We found a significant increase of Iba-1, indicative of microglia activation, although the overall levels of IL-1β, IL-6, TNFα, IL-4, IL-10, and TGFβ mRNA transcripts were not different between the treatment groups. …”
  11. 1811
  12. 1812
  13. 1813

    Recruitment flow diagram of the current study. by Somayeh Momenyan (10111603)

    Published 2025
    “…Phase 1 EQ-VAS decreases were associated with female sex, lower somatic symptom, fewer comorbidities, lack of expectation for a fast recovery, higher ISS, higher injury pain, neck, spine/back or lower extremity injuries. …”
  14. 1814
  15. 1815

    S1 Raw data - by Muhammad Naeem Sattar (19828497)

    Published 2024
    “…The larval duration was also decreased significantly in the larvae treated with all the dsRNA treatments. …”
  16. 1816
  17. 1817
  18. 1818

    <b> </b> Rate of brain weight to body weight in different experimental groups. AlCl3 treatment caused a significant decrease in brain-to-body weight with respect to the control group (P < 0.01). 2 or 5 injections of BM-MSC extracted exosomes significantly protected against the deficit effect of Alcl3 on brain-to-body weight rate.... by Atefeh Sadeghi (21253051)

    Published 2025
    “…AlCl3 treatment caused a significant decrease in brain-to-body weight with respect to the control group (P < 0.01). 2 or 5 injections of BM-MSC extracted exosomes significantly protected against the deficit effect of Alcl3 on brain-to-body weight rate. …”
  19. 1819
  20. 1820